PUBLIC COMPANY
save$ZLABZai Lab Ltd
$ZLAB22.11-6.03%Shanghai, CNupdated 9h ago
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Preclinical1Phase 11Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →🐶 Hiring Signal
News
- Molecular Partners to lay off up to 44% of workforce in radiotherapy pivotMolecular Partners plans to lay off up to 44% of its staff as it focuses its declining cash reserves on a radiotherapeutic pipeline led by an early-phase small cell lung cancer drug candidate.fiercebiotech · 20d ago
- ESMO 2026: Amgen’s Imdelltra slashes death risk by nearly 60% in small cell lung cancerWhen used alongside AstraZeneca’s Imfinzi, the bispecific T cell engager Imdelltra extended survival by eight months versus Imfinzi alone in Phase 3 study testing the combo in a first-line maintena…biospace · 23d ago
- #ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and moreThe last time the ESMO congress was in Madrid, a presentation on first-line data in bladder cancer drew a rapturous standing ovation. Contenders that might draw the same reception include hotly ant…endpoints · 1mo ago
- Merck, Daiichi end plans to seek speedy approval of lung cancer ADCThe FDA indicated that the data generated so far wouldn’t support an accelerated clearance of “I-DXd,” a setback that erases an edge Merck and Daiichi had over multiple fast-moving competitors.biopharma_dive · 1mo ago
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that